{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670320233047296.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/0024-3205(76)90170-3"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:0024320576901703?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:0024320576901703?httpAccept=text/plain"}}],"dc:title":[{"@value":"Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670320233047296","@type":"Researcher","foaf:name":[{"@value":"Robert C. Smith"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670320233047424","@type":"Researcher","foaf:name":[{"@value":"John M. Davis"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00243205"}],"prism:publicationName":[{"@value":"Life Sciences"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"1976-09","prism:volume":"19","prism:number":"5","prism:startingPage":"725","prism:endingPage":"731"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:0024320576901703?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:0024320576901703?httpAccept=text/plain"}],"createdAt":"2002-12-14","modifiedAt":"2019-04-01","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002218712825344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679266039168","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Further dopaminergic supersensitivity to dopamine agonists by subchronic administration of haloperidol in rats treated with colchicine."},{"@value":"Further Dopaminergic Supersensitivity to Dopamine Agon sts by Subchronic Administration of Haloperidol in Rats Treated with Colchicine"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/0024-3205(76)90170-3"},{"@type":"CROSSREF","@value":"10.1159/000477313_references_DOI_BPaXKgTzXlfRmfEijyIyUg224bf"},{"@type":"CROSSREF","@value":"10.1254/jjp.42.329_references_DOI_BPaXKgTzXlfRmfEijyIyUg224bf"}]}